ATRC vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

ATRC

36.1
AI Score
VS
XRAY Wins

XRAY

53.9
AI Score

Investment Advisor Scores

ATRC

36score
Recommendation
EXTENDED

XRAY

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ATRC XRAY Winner
Forward P/E 256.4103 7.4627 XRAY
PEG Ratio 10 0.746 XRAY
Revenue Growth 12.8% -4.1% ATRC
Earnings Growth 0.0% 15.2% XRAY
Tradestie Score 36.1/100 53.9/100 XRAY
Profit Margin 1.8% -15.0% ATRC
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

ATRC 1M: +48.4% · 3M: +70.0% XRAY 1M: -14.2% · 3M: +10.0%

Current Technical Phase

ATRC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (19.5% over 20 days), RSI 84

RSI (14): 83.8 · Price: $48.98

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

Fundamentals Snapshot

Metric ATRC XRAY
Market Cap
Forward P/E 113.4 7.2
Trailing P/E 226.1
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.5%
Operating Margin 0.1% 0.1%
EPS 0.21 -2.71
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.